Late investor Rakesh Jhunjhunwala-backed Concord Biotech’s (CBL) Rs 1,550 crore-initial public offer (IPO) will open for subscription today and close on August 7. The issue is entirety an offer for sale, wherein investor Helix Investment Holdings is selling its 20 per cent stake. The price band is fixed at Rs 705-741 a share. … Continue reading Jhunjhunwala-backed Concord Biotech IPO opens today: What do analysts say?
Tag: Jhunjhunwalabacked
Jhunjhunwala-backed Concord Biotech eyes to raise Rs 1,550 cr through IPO
Ahmedabad-based Concord Biotech, makers of fermentation-based bulk drugs, is aiming to raise between Rs 1,475.26 crore and Rs 1,550.59 crore from an initial public offering (IPO) set to open on Friday. Rakesh Jhunjhunwala-backed Concord Biotech Ltd has fixed a price band between Rs 705 and Rs 741 a share. The public issue of… Continue reading Jhunjhunwala-backed Concord Biotech eyes to raise Rs 1,550 cr through IPO